Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × Ifosfamide × Clear all

Sponsor

Conditions

Sarcoma 22 Lymphoma 13 Hodgkin Disease 11 Osteosarcoma 10 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 6 Ovarian Neoplasms 6 Neoplasms 6 Lymphoma, Non-Hodgkin 6 Recurrence 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Testicular Germ Cell Tumor 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Germ Cell Cancer 3 Neurofibrosarcoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Histiocytoma, Malignant Fibrous 3 Fibrosarcoma 3 Endodermal Sinus Tumor 3 Carcinoma, Embryonal 3 Vomiting 2 Seminoma 2 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡